The highest tirzepatide dose (15mg) produced an average weight loss of 11.2kg compared to 5.7kg with semaglutide 1mg
Previous studies on the efficacy of oral antihyperglycemic agent triple combination therapy have been, for the most part, conducted with add-on therapy with metformin and sulfonylurea [21]
Insulin helps move sugar from your blood into the cells, where it is used to produce energy
These claims are not supported by credible science or independent clinical trials
Most patients continued to lose weight during their time on the full dosage as well
In addition to their potent metabolic actions that reduce hyperglycaemia and body weight, GLP-1RAs also lower the risk of major kidney, cardiovascular and mortality outcomes across broad populations with cardiovascular disease or CKD, with and without diabetes or obesity